Stock screener

COLL

Conviction 24HealthcareScan · Mon, Aug 10, 2026
COLL$27.20-7.70%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 568.63K
May 11May 28Jun 16Jul 6Jul 23Aug 10
COLLEGIUM PHARMACEUTICAL, INCPHARMACEUTICAL PREPARATIONSwww.collegiumpharma.com
Price27.20
Change-7.70%
Gap-2.41%
Rel volume3.13×
Avg volume525.96K
Avg $ vol17.16M
SMA 2034.65
SMA 5034.58
SMA 20039.28
Price vs 50-21.35%
Price vs 200-30.75%
MA stackbearish
50/200 cross
Supertrenddown · 33.81
RSI (14)23
MACD hist-0.93
MACD cross
Stoch %K / %D1 / 7
ADX (14)20
+DI / −DI10 / 41
RSI divergence
MACD divergence
ATR %+6.51%
ADR %4.54%
52w high49.84
52w low27.20
From 52w high-45.43%
Above 52w low+0.00%
New 52w highNo
SqueezeOff
Bollinger width30.12%
%B-0.21
Donchian pos0.66%
Donchian high37.70
Donchian low27.13
AVWAP (52w high)37.40
vs AVWAP high-27.26%
AVWAP (52w low)27.81
vs AVWAP low-2.18%
OBV trendFlat
Chaikin MF (20)-0.25
Today vs 20d3.13×
Avg vol (14d)568.63K
Avg vol (20d)525.96K
Avg $ vol (20d)17.16M
Market cap885.51M
RS 3m (vs SPY)-30.77%
RS 6m (vs SPY)-51.31%
RS line new highNo
Trend template1/8
Technical rank6.5
1 week-23.55%
1 month-22.79%
3 months-28.04%
6 months-42.87%
1 year-17.43%
YTD-40.26%
P/E14.08
P/B2.84
P/S1.13
P/FCF2.70
EPS1.73
Div yield
ROE20.16%
ROA2.94%
Debt/Eq0.05
Current1.03
EV/EBITDA4.27
Gross margin59.35%
Net margin8.05%
Rev growth23.62%
EPS growth-9.13%
Price target51.25
Target upside88.42%
Analyst ratingBuy
Institutional125.06%
Ent. value770.21M
Revenue199.88M
Net income-15.05M
Gross profit110.29M
Free cash flow327.58M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out32.43M
Employees423
ListedThu, May 7, 2015
Free float30.41M
Float %93.8%
Short interest5.23M
Days to cover11.2d
Short volume55.2%
Squeeze score85 / 100
Next earnings
EPS forecast
Last EPS vs est$1.57 vs $1.48
Last surprise+6.1% beat
Setup gradeD
Conviction24 / 100
Pattern quality
Tech rank6.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance38.10
Support32.85
Days since event
Candle confirm
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in COLL

All disclosures →
No recent disclosed trades by Congress in COLL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in COLL · 4 buys · 4 sells

InsiderSideShares
SANTINI GINO
Director · Stock Option (Right to Purchase) · 2026-06-08
Exercise8.7K
SANTINI GINO
Director · Common Stock · 2026-06-08
Exercise8.7K
Freund John Gordon
Director · Common Stock · 2026-05-18
Other
Freund John Gordon
Director · Common Stock · 2026-05-18
Sell20
Freund John Gordon
Director · Common Stock · 2026-05-15
Exercise8.7K
Freund John Gordon
Director · Stock Option (Right to Purchase) · 2026-05-15
Exercise8.7K
Freund John Gordon
Director · Common Stock · 2026-05-15
Sell4.13K
Balice-Gordon Rita J.
Director · Common Stock · 2026-05-14
Grant8.74K
SANTINI GINO
Director · Common Stock · 2026-05-14
Grant8.74K
Freund John Gordon
Director · Common Stock · 2026-05-14
Other

SEC filings

EDGAR filings in COLL · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.